The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.
Continue Reading
A patient’s immune system can often react badly to bone marrow transplants. Mesenchymal stromal cells (MSCs) may help, but they too can be cleared out by immune cells. Now, a Harvard team has shown that coating MSCs in a thin hydrogel can protect them, making bone marrow transplants more successful.
Continue Reading
There exists a group of HIV-positive people who have a rare ability to naturally control the HIV infection. Now, after years of research, a team of scientists from the Institut Pasteur in Paris, has successfully reprogrammed cells that lack this ability, giving them the same, antiviral potency.
Continue Reading
Wearable health-monitors are everywhere, from Fitbits for the health conscious to continuous glucose monitors for diabetics, but most are limited in what they can tell us, and there are issues around accuracy, calibration and reliability. Researchers in Sweden are working to change that.
Continue Reading
A new two-step diagnostic process is claiming to confidently detect Alzheimer's disease nearly a decade before clinical symptoms appear. It's hoped that the method will improve the results of clinical trials by helping better identify patients at the earliest stages of the disease.
Continue Reading
For decades, sufferers of chronic fatigue syndrome have battled to prove this illness is not a psychological condition, but in fact an actual biological disease. Now a team has developed a new type of blood test that could offer doctors the first diagnostic tool to identify it.
Continue Reading
As part of a decade-long research project a newly published study has revealed the development of a blood test that can purportedly identify patients most at risk of developing post-traumatic stress disorder (PTSD), and possibly even predict future psychiatric hospitalizations.
Continue Reading
A team of scientists from the University of Illinois at Chicago and Queensland University of Technology in Australia has demonstrated a new, cheap and fast device that can detect floating cancer cells in a tiny blood sample.
Continue Reading
For centuries humans have anecdotally espoused the rejuvenating properties of young blood, however it is only recently that scientists have begun to seriously explore the idea. A new study has homed in on a potential hypothesis revealing young bone marrow transplants improved memory in old mice.
Continue Reading
Ambrosia, the controversial medical startup selling transfusions of youthful blood under the premise it confers anti-aging benefits, has swiftly ceased operations hours after the FDA issued an oblique statement suggesting the treatment has not been proven to be safe or effective.
Continue Reading
See the stories that matter in your inbox every morning